Li H, He W, Lin H, Du A, Zhang X, Yang H, & Qu S. (2024). Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis. Dove Medical Press.
Chicago Style (17th ed.) CitationLi H, He W, Lin H, Du A, Zhang X, Yang H, and Qu S. Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis. Dove Medical Press, 2024.
MLA (9th ed.) CitationLi H, et al. Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis. Dove Medical Press, 2024.
Warning: These citations may not always be 100% accurate.